Eitan Medical launches connected Avoset Infusion Platform
28 Apr 2023
Avoset Infusion Platform is set to redefine post-acute care
Avoset Infusion System (Credit: PRNewsfoto/Eitan Medical Ltd)
Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions with reliable innovations that put patients at the center of care, announced today, the launch of its new cutting-edge connected infusion multi-therapy ambulatory infusion system – Avoset.
The connected Avoset Infusion System is designed to transform post-acute care and specialty infusion therapy with compact and simplified technology that can monitor infusion treatment data remotely, aiming to enhance patient safety, and improve the user experience.
The AvosetTM Infusion Platform complements the Sapphire Infusion portfolio and is especially well positioned to address infusion needs for therapies which require secure medication reservoirs and long battery life at low flow rates.
The Avoset Infusion Pump is MDR certified and is currently available in selected European countries. Eitan Medical is looking forward to rolling out Avoset on an international scale in 2023.
Shaul Eitan, GM and President of Eitan Medical, Medication Delivery Solutions, commented: “The recent spinout of Eitan Medical’s Sorrel wearable injection device business, allows Eitan Medical to focus on its core connected infusion system solutions. The launch of Avoset will transform infusion therapy in alternate sites and is not only a triumph of innovation and technology, but also a testament to the dedication of Eitan Medical in providing the best possible care for patients. It is a moment of excitement and hope, as we look forward to the transformative impact these solutions will have on the lives of many patients and caregivers around the world.”
Roger Massengale, Chief Commercial Officer, stated: “We are thrilled to launch the Avoset Infusion Platform, an innovative connected ambulatory infusion pump that will transform the way patients receive treatment in post-acute care. We are confident that this new infusion pump will make a positive impact on the lives of patients and their caregivers, providing them with the freedom and flexibility to manage their treatment from the comfort of their own homes. This confirms that Eitan Medical is set for sustainable growth with a focus on a strong innovation roadmap that will redefine the drug delivery market.”
Source: Company Press Release
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.